DEVICE CATEGORY · SBL
Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4
Melanoma-associated antigen A4 (MAGE-A4) antibody is a qualitative immunohistochemical antibody, intended for use in the detection of MAGE-A4 protein expression in human clinical tissue specimens. The MAGE A4 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MAGE-A4 IHC 1F9 pharmDxP230016/S004 | Agilent Technologies, Inc. | PMA supplement | Sep 21, 2026 | FDA |
MAGE-A4 IHC 1F9 pharmDxP230016/S003 | Agilent Technologies, Inc. | PMA supplement | Sep 15, 2026 | FDA |
MAGE-A4 IHC 1F9 pharmDxP230016/S005 | Agilent Technologies, Inc. | PMA supplement | Sep 11, 2026 | FDA |
MAGE-A4 IHC 1F9 pharmDxP230016 | Agilent Technologies, Inc. | PMA approval | Aug 1, 2024 | FDA |
Source information
Follow the FDA links to view the original records.



